Skip to main content
. 2021 Sep 11;6(6):100798. doi: 10.1016/j.adro.2021.100798

Fig. 2.

Fig 2

Bars represent individual intracranial and systemic control assessed by Response Assessment in Neuro-Oncology Brain Metastases Criteria and immune-related Response Evaluation Criteria in Solid Tumors Criteria, respectively. Also detailed are additional treatments received by patients and ongoing responses as well as receptor subtypes. Abbreviations: HR = hormone receptor; TN = triple negative.